policies >  DOI:10.25504/FAIRsharing.7KZpOx

ready Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma)

General Information

Homepage https://druggablegenome.net/IDGPolicies#Policy7

Countries that developed this resource Denmark , United Kingdom , United States

Published in 2018

Type: Project


IDG members are encouraged to foster collaborations and interactions with individual laboratories/researchers, consortia, associations, pharma, and biotech, as well as other outside entities. The guidelines outlined here are to enhance these interactions for the benefit of sharing IDG outcomes.

Collections/recommendations derived from this policy:

Taxonomic range

Knowledge Domains

How to cite this record FAIRsharing.org: Policy for IDG Consortium Interaction with Other Entities (Consortia/Institutes /Associations/Biotech/Pharma); DOI: https://doi.org/10.25504/FAIRsharing.7KZpOx; Last edited: Dec. 19, 2019, 11:07 a.m.; Last accessed: Apr 17 2021 7:04 a.m.

This record is maintained by dvidovic  ORCID

Record added: Oct. 3, 2019, 4:10 p.m. Record updated: Nov. 4, 2019, 11:31 a.m. by The FAIRsharing Team.
Show edit history


Record Maintainer


  • NIH (Government body)


Policy External Cross References

TOP Level Data Transparency: Not available

TOP qualifying comments: Not available

Standards and Databases mentioned in this policy


No Databases Listed


No Standards Listed

Usage / Access

Conditions of Use


No support information provided.

Additional Information